Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026)
Bruker (BRKR) posted Net Income towards Common Stockholders of $3.5 million for Q1 2026, down 76.51% on a QoQ basis from $14.9 million in Q4 2025, and down 79.89% year-over-year from $17.4 million in Q1 2025.
Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Bruker's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 79.89% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$50.0 million (down 162.81% YoY) and the FY2025 annual result came in at -$22.5 million, down 119.89% from the prior year.
- Net Income towards Common Stockholders was $3.5 million for Q1 2026 at Bruker, down from $14.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $205.5 million in Q4 2023 and bottomed at -$62.4 million in Q3 2025.
- A 5-year average of $47.3 million and a median of $49.5 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders jumped 110.99% — and 2025, when it sank 252.57%.
- Bruker's Net Income towards Common Stockholders stood at $97.4 million in 2022, then soared by 110.99% to $205.5 million in 2023, then slumped by 93.33% to $13.7 million in 2024, then rose by 8.76% to $14.9 million in 2025, then sank by 76.51% to $3.5 million in 2026.
- Business Quant data shows BRKR's Net Income towards Common Stockholders at $3.5 million in Q1 2026, $14.9 million in Q4 2025, and -$62.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Bruker | 9.14 Bn | 9.14 Bn | 379.80 Mn | 3.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.50 Mn |
| Dec 31, 2025 | 14.90 Mn |
| Sep 30, 2025 | -62.40 Mn |
| Jun 30, 2025 | -6.00 Mn |
| Mar 31, 2025 | 17.40 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | 40.90 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Mar 31, 2024 | 50.90 Mn |
| Dec 31, 2023 | 205.50 Mn |
| Sep 30, 2023 | 88.10 Mn |
| Jun 30, 2023 | 57.10 Mn |
| Mar 31, 2023 | 76.50 Mn |
| Dec 31, 2022 | 97.40 Mn |
| Sep 30, 2022 | 88.10 Mn |
| Jun 30, 2022 | 49.50 Mn |
| Mar 31, 2022 | 61.60 Mn |
| Dec 31, 2021 | 75.70 Mn |
| Sep 30, 2021 | 87.10 Mn |
| Jun 30, 2021 | 57.60 Mn |